Clinical study to evaluate the safety and performance of the CardiAQ-Edwards™ Transcatheter Mitral Valve
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Freedom from major adverse cardiac and cerebrovascular events
Timeframe: 30 days
Freedom from individual adverse events
Timeframe: 30 days